Protozoal diseases Visceral Leishmaniasis Kala azar Leishmania donovani Vectors Sandflies Phlebotomus argentipes Drug resistance SSG Antimonials Treatment failure Genetic markers Genome sequencing Strains Haplotypes Identification Assays India Asia, South
Abstract:
The current standard to assess pentavalent antimonial (SSG) susceptibility of Leishmania is a laborious in vitro assay of which the result has little clinical value because SSG-resistant parasites are also found in SSG-cured patients. Candidate genetic markers for clinically relevant SSG-resistant parasites identified by full genome sequencing were here validated on a larger set of clinical strains. We show that 3 genomic locations suffice to specifically detect the SSG-resistant parasites found only in patients experiencing SSG treatment failure. This finding allows the development of rapid assays to monitor the emergence and spread of clinically relevant SSG-resistant Leishmania parasites.